title: Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease.
abstract: We have defined proximal lower limb ischaemia as a decrease in Exercise-transcutaneous oxygen pressure (TcPO(2)) lower than minus 15mmHg at the buttock level in patients with peripheral artery occlusive disease. The purpose of this study was to objectively evaluate the benefits of direct versus indirect revascularisation of internal iliac arteries (IIAs) for prevention of buttock claudication in this population. We retrospectively reviewed the charts of proximal ischaemia patients who underwent revascularisation and both preoperative and postoperative stress TcPO(2) testing. Revascularisation procedures were classified as either direct revascularisation, including percutaneous transluminal angioplasty and internal iliac artery bypass, resulting in a direct inflow in a patent IIA (group 1) or indirect revascularisation, including aortobifemoral bypass and recanalisation of the femoral junction on the ischaemic side, resulting in indirect inflow from collateral arteries in the hypogastric territory (group 2). Patency was checked 3 months after revascularisation in all cases. Treadmill exercise stress tests were performed before and after revascularisation using the same protocol designed to assess pain, determine maximum walking distance (MWD) and measure TcPO(2) during exercise. In addition, ankle-brachial indices (ABIs) were calculated. Between May 2001 and March 2008, a total of 93 patients with objectively documented proximal ischaemia underwent 145 proximal revascularisation procedures using conventional open techniques in 109 cases and endovascular techniques in 36. Direct revascularisation was performed on 50 limbs (35%) (group 1) and indirect revascularisation on 95 limbs (65%) (group 2). The mean interval between revascularisation and stress testing was 60+/-74 days preoperatively and 149+/-142 days postoperatively. No postoperative thrombosis was observed. Buttock claudication following revascularisation was more common in group 2 (p<0.001). No difference was observed between the two groups with regard to improvement in MWD (365 / 294 m) and ABI (0.20/0.22). Disappearance of proximal ischaemia was more common after direct revascularisation (p<0.01). The extent of lesions graded according to the TASC II classification appeared not to be predictive of improvement in assessment criteria following revascularisation. Conversely, patency of the superficial femoral artery was correlated with improvement (p<0.01). This study indicates that direct revascularisation, if feasible, provides the best functional outcome for prevention of buttock claudication.
authors.affiliation: Department of Vascular and Thoracic Surgery, University Hospital, Angers, France.
authors.forename: A
authors.initials: A
authors.lastname: Paumier
authors.forename: P
authors.initials: P
authors.lastname: Abraham
authors.forename: G
authors.initials: G
authors.lastname: Mahé
authors.forename: E
authors.initials: E
authors.lastname: Maugin
authors.forename: B
authors.initials: B
authors.lastname: Enon
authors.forename: G
authors.initials: G
authors.lastname: Leftheriotis
authors.forename: J
authors.initials: J
authors.lastname: Picquet
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon / Q000009:adverse effects; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D001785:Blood Gas Monitoring, Transcutaneous; D002081:Buttocks / Q000098:blood supply*; D003251:Constriction, Pathologic; D005080:Exercise Test; D017079:Exercise Tolerance; D005260:Female; D006801:Humans; D007083:Iliac Artery / Q000503:physiopathology / Q000601:surgery*; D007383:Intermittent Claudication / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D007511:Ischemia / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010388:Pelvis / Q000098:blood supply*; D020127:Recovery of Function; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014654:Vascular Patency; D014656:Vascular Surgical Procedures / Q000009:adverse effects
chemical_list: D010100:Oxygen